AAAAAA
Results: 26-39/39
Authors:
Szefler, SJ
Citation: Sj. Szefler, Clinical need for a nebulized corticosteroid, J ALLERG CL, 104(4), 1999, pp. S162-S168
Authors:
Szefler, SJ
Citation: Sj. Szefler, Pharmacodynamics and pharmacokinetics of budesonide: A new nebulized corticosteroid, J ALLERG CL, 104(4), 1999, pp. S175-S183
Authors:
Nelson, HS
Szefler, SJ
Jacobs, J
Huss, K
Shapiro, G
Sternberg, AL
Citation: Hs. Nelson et al., The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program, J ALLERG CL, 104(4), 1999, pp. 775-785
Authors:
Leung, DYM
Nelson, HS
Szefler, SJ
Citation: Dym. Leung et al., Monosodium glutamate asthma - Another additive exonerated, J ALLERG CL, 104(2), 1999, pp. 249-249
Authors:
Leung, DYM
Nelson, HS
Szefler, SJ
Citation: Dym. Leung et al., Proteasome inhibition: A new approach to combat asthma?, J ALLERG CL, 104(2), 1999, pp. 249-249
Authors:
Leung, DYM
Nelson, HS
Szefler, SJ
Citation: Dym. Leung et al., Chromosome 12q and linkage to asthma, J ALLERG CL, 104(2), 1999, pp. 249-249
Authors:
Hauk, PJ
Wenzel, SE
Trumble, AE
Szefler, SJ
Leung, DYN
Citation: Pj. Hauk et al., Increased T-cell receptor V beta 8+T cells in bronchoalveolar lavage fluidof subjects with poorly controlled asthma: A potential role for microbial superantigens, J ALLERG CL, 104(1), 1999, pp. 37-45
Authors:
Wamboldt, FS
Bender, BG
O'Connor, SL
Gavin, LA
Wamboldt, MZ
Milgrom, H
Szefler, SJ
Ikle, D
Rand, C
Citation: Fs. Wamboldt et al., Reliability of the Model MC-311 MDI Chronolog, J ALLERG CL, 104(1), 1999, pp. 53-57
Authors:
Fost, DA
Leung, DYM
Martin, RJ
Brown, EE
Szefler, SJ
Spahn, JD
Citation: Da. Fost et al., Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy, J ALLERG CL, 103(6), 1999, pp. 1031-1035
Authors:
Szefler, SJ
Boushey, HA
Pearlman, DS
Togias, A
Liddle, R
Furlong, A
Shah, T
Knobil, K
Citation: Sj. Szefler et al., Time to onset of effect of fluticasone propionate in patients with asthma, J ALLERG CL, 103(5), 1999, pp. 780-788
Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin
Authors:
Spahn, JD
Leung, DYM
Chan, MTS
Szefler, SJ
Gelfand, EW
Citation: Jd. Spahn et al., Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin, J ALLERG CL, 103(3), 1999, pp. 421-426
Authors:
Kamada, AK
Szefler, SJ
Citation: Ak. Kamada et Sj. Szefler, Glucocorticoids, LUNG BIOL H, 126, 1999, pp. 327-362
Authors:
Szefler, SJ
Oliver, S
Bender, B
Nelson, H
Culkin, C
Taggart, V
Citation: Sj. Szefler et al., Design and implementation of a patient education center for the childhood asthma management program, ANN ALLER A, 81(6), 1998, pp. 571-581
Authors:
Chu, HW
Halliday, JL
Martin, RJ
Leung, DYM
Szefler, SJ
Wenzel, SE
Citation: Hw. Chu et al., Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease, AM J R CRIT, 158(6), 1998, pp. 1936-1944